IMEDEAi004-B

Registration Summary:

A P E C

iPS GM00879CL9

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	IMEDEAi004-B
Cite as:	IMEDEAi004-B (RRID:CVCL_UD90)
Alternative name(s)	iPS GM00879CL9
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	18th July 2018
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Instituto Mediterraneo de Estudios Avanzados (IMEDEA)
External Databases
Cellosaurus	CVCL_UD90
Wikidata	Q94316119
General Information
Publications	Vallejo S et al. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B. Stem cell research. 2018 Oct;32:110-114. Wang AYL et al. Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications. Cell transplantation. 2019 Dec;28(1_suppl):112S-131S. Pearse Y et al. A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise. Medical research archives. 2020 Feb 1;8(2). Benetó N et al. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches. International journal of molecular sciences. 2020 Oct 22;21(21). Lehmann RJ et al. Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells. Molecular genetics and metabolism reports. 2021 Dec;29:100811. Veraldi N et al. Characterization of a spontaneous cell line from primary mouse fibroblasts as a model to study Sanfilippo syndrome. The international journal of biochemistry & cell biology. 2022 Jan;142:106119. Carvalho Sofia et al. Neurological Disease Modeling Using Pluripotent and Multipotent Stem Cells: A Key Step towards Understanding and Treating Mucopolysaccharidoses. Biomedicines. 2023-04-21.

hIPSC Derivation

General